Jefferson Health

Jefferson Health Establishes the Stephen and Sandra Sheller Consult and Bridge Program to Provide Person-Centered Care for People with Substance Use Disorder

Retrieved on: 
Thursday, May 2, 2024
Family, Public health, Patient, Food, Jefferson Health, Ecosystem, Opioid use disorder, Risk, Housing, Health, The Pew Charitable Trusts, Substance use disorder, FAAFP, Buprenorphine, Methadone, Thomas Jefferson University, Master of Science, Physician, Bridge program, Sheller, Pew, FACP, MPP, Nursing

PHILADELPHIA, May 2, 2024 /PRNewswire/ -- Today, Jefferson Health announced the opening of the Stephen and Sandra Sheller Consult and Bridge Program. The Bridge Program is an ecosystem of coordinated, high-quality care for people with severe substance use disorder. In this model, a single interdisciplinary care team provides comprehensive services for the Bridge patients across community, hospital, emergency department, and psychiatry settings. In addition to the full spectrum of health needs, the program's staff assists patients with social needs such as housing, legal assistance, and food insecurity. The Stephen and Sandra Sheller Consult Bridge Program serves as a vital safe harbor for patients in the earliest stages of medical and substance use recovery.

Key Points: 
  • The Bridge Program is an ecosystem of coordinated, high-quality care for people with severe substance use disorder.
  • The Stephen and Sandra Sheller Consult Bridge Program serves as a vital safe harbor for patients in the earliest stages of medical and substance use recovery.
  • The Bridge Program is an ecosystem of coordinated, high-quality care for people with severe substance use disorder
    "Jefferson Health is committed to creating innovative new programs for delivering compassionate, person-centered care.
  • "We enthusiastically chose Jefferson Health to be the recipient of our foundation funds for this new Stephen and Sandra Sheller Consult and Bridge Program.

AISAP Raises $13 Million in Seed Funding for First AI-Powered, Point Of Care Ultrasound Diagnostic Solution

Retrieved on: 
Thursday, May 2, 2024
Emergency department, Mayo Clinic, Deep learning, Jefferson Health, TEL, Mossad, Death, Cyber, Life, Intelligence, Sheba Medical Center, Echocardiography, IDL, Patient, POCUS, Financial services, Diagnosis, Internal medicine, Algorithm, Ultrasound, Medical imaging

TEL AVIV, Israel, May 2, 2024 /PRNewswire/ --  AISAP, whose AI-powered Point Of Care Assisted Diagnosis (POCAD)™ solution is transforming the medical ultrasound industry, announced its seed funding round today. The company secured $13 million, led by Harel Insurance Investments & Financial Services Ltd. and Shoni Top Ventures, L.P.

Key Points: 
  • AISAP's POCAD™ solution solves this challenge by providing AI-powered diagnoses that are both highly accurate and easy for any physician to understand – not just ultrasound experts.
  • Unlike most other POCUS devices, AISAP's POCAD™ solution can even provide detailed, accurate diagnoses of specific valves within the cardiovascular systems.
  • And while the average ultrasound takes weeks on average to provide a full analysis and diagnosis, AISAP's solution does so in as little as 5 minutes.
  • In 29% of those cases, the AISAP solution discovered at least one previously-unknown, moderate medical condition.

Jefferson Health and Air Methods Partner in Carbon Offset Program

Retrieved on: 
Wednesday, April 17, 2024
Climate change, The, Fresh water, Jefferson Health, Environmental health, Certification, Health, Pollutant, National Forest, MD, Air Methods, Partnership, Carbon, Tree, LEED, National Forest Foundation

PHILADELPHIA, April 17, 2024 (GLOBE NEWSWIRE) -- JeffSTAT, Jefferson Health’s medical transportation service, and Air Methods, the nation’s leading air medical services provider, have partnered together as part of a carbon offset program with the National Forest Foundation—the first of its kind in the air medical services field.

Key Points: 
  • PHILADELPHIA, April 17, 2024 (GLOBE NEWSWIRE) -- JeffSTAT, Jefferson Health’s medical transportation service, and Air Methods, the nation’s leading air medical services provider, have partnered together as part of a carbon offset program with the National Forest Foundation—the first of its kind in the air medical services field.
  • Air Methods and Jefferson Health together provide approximately 2,300 patient flights per year.
  • By partnering with JeffSTAT on this program, we are demonstrating our commitment to sustainability and environmental stewardship,” said Air Methods CEO JaeLynn Williams.
  • Jefferson Health’s new carbon offset program is one of many ways that the organization is working to improve environmental health.

Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer

Retrieved on: 
Thursday, April 11, 2024
DREAM, Jefferson Health, Education, Publication, Euronext, Surgeon, MD, Obstructive sleep apnea, Thomas Jefferson University, Patient, Mont-Saint-Guibert, Head, Otorhinolaryngology, Sleep, OSA

Mont-Saint-Guibert, Belgium – April 11, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the appointment of Dr. Maurits S. Boon, MD as Chief Medical Officer.

Key Points: 
  • Mont-Saint-Guibert, Belgium – April 11, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the appointment of Dr. Maurits S. Boon, MD as Chief Medical Officer.
  • Boon joins Nyxoah from the Thomas Jefferson University, where he will continue part time as a professor and Vice Chairman, Education.
  • As such, I am honored to have been offered a position to join Nyxoah at such an exciting time.
  • He is one of the pioneers in hypoglossal nerve stimulation and his decision to become Nyxoah’s Chief Medical Officer reflects Genio’s ability to improve the lives of OSA patients,” commented Olivier Taelman, Chief Executive Officer.

National Cancer Institute Designates Jefferson's Sidney Kimmel Cancer Center as a Comprehensive Cancer Center

Retrieved on: 
Thursday, April 18, 2024
Education, Mortality, Patient, Cancer, Jefferson Health, Person, Massage, Heart, Partnership, National Cancer Institute, Research, Thomas Jefferson University, Environment, Comprehensive, Science, Incidence, Privacy, Master of Science, NCI, Drexel University, Center City, Philadelphia, Disease, Cardiovascular disease, Diagnosis, Health, Interim, SKCC, FACP, MPP, Pharmaceutical industry

PHILADELPHIA, April 18, 2024 /PRNewswire/ -- Today, Jefferson announced that its Sidney Kimmel Cancer Center (SKCC) has earned a National Cancer Institute (NCI) "Comprehensive" Cancer Center designation, the highest recognition awarded by the NCI. 

Key Points: 
  • As part of the Sidney Kimmel Cancer Center Research Consortium, Thomas Jefferson University and Drexel University have partnered to transform breakthrough research into life-changing cancer treatments
    PHILADELPHIA, April 18, 2024 /PRNewswire/ -- Today, Jefferson announced that its Sidney Kimmel Cancer Center (SKCC) has earned a National Cancer Institute (NCI) "Comprehensive" Cancer Center designation, the highest recognition awarded by the NCI.
  • "We at Jefferson have always known that the Sidney Kimmel Cancer Center is among the best of the best.
  • said Andrew Chapman, DO, FACP, EVP Cancer Research and Oncology Services, and Director, Sidney Kimmel Cancer Center, Jefferson Health.
  • As partners in the Sidney Kimmel Cancer Center Research Consortium, Jefferson, along with Drexel University, is focused on transforming breakthrough research into life-changing cancer treatment.

Kyverna Therapeutics to attend the 2024 American Academy of Neurology (AAN) Annual Meeting in Denver, CO, With Data on KYV-101 in the Treatment of Patients with Neurological Autoimmune Diseases

Retrieved on: 
Thursday, April 11, 2024
Stanford University, American Academy, FAAN, KYTX, Safety, Lambert–Eaton myasthenic syndrome, Jefferson Health, CD19, Patient, AAN, Teaching hospital, Therapy, Pharmaceutical industry

EMERYVILLE, Calif., April 11, 2024 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, announced today its attendance at the 2024 annual meeting of the American Academy of Neurology to be held in Denver, Colorado, starting on April 13.

Key Points: 
  • EMERYVILLE, Calif., April 11, 2024 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, announced today its attendance at the 2024 annual meeting of the American Academy of Neurology to be held in Denver, Colorado, starting on April 13.
  • "We look forward to attending AAN and engaging with the scientific community in seeking to develop paradigm-shifting treatment options for patients living with autoimmune diseases," said Peter Maag, Ph.D., chief executive officer of Kyverna.
  • Chimeric antigen receptor (CAR) T-cell therapy involves modifying a patient's T cells to recognize and remove B cells in the patient's body.
  • CD19 CAR T-cell therapy specifically targets CD19, a protein expressed on the surface of B cells, which are involved in various types of autoimmune diseases.

Jefferson Defines the Future of Health Care with the Honickman Center

Retrieved on: 
Wednesday, March 13, 2024
Operating, Master of Science, Patient, Jefferson Health, FACP, MPP, Pharmacy, Bellone, Hospital

PHILADELPHIA, March 13, 2024 /PRNewswire/ -- Today, Jefferson Health announces that the construction of the state-of-the-art, patient-focused Honickman Center is complete. The facility will welcome patients starting on April 15, 2024.

Key Points: 
  • "The Honickman Center stands as our flagship medical facility in Center City and as the epicenter of a more than $1 billion urban development project in East Market.
  • The Honickman Center will offer convenient and centralized access to a broad range of signature medical specialties.
  • The Honickman Center enables Jefferson to provide patients and clinicians with a seamless care experience.
  • "The Honickman Center also represents the future of healthcare by blending physical and virtual care while enhancing the human interaction between a patient and their care provider."

The Inner Circle Acknowledges, Bohdan Minczak as a Pinnacle Lifetime Member

Retrieved on: 
Wednesday, March 6, 2024
Love, Saint Joseph's College, Jefferson Health, College, Doctor of Philosophy, Inner circle, Medicine, Education, MD, Emergency medicine, Physician, Temple University, Master, Biophysics, Bachelor, Mentorship, Pharmacology, Thomas Jefferson University, Associate, Patient, Family, ABEM, Knowledge, Research, Thomas Jefferson, Nursing

CHELTENHAM, Pa., March 6, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Bohdan Minczak is acknowledged as a Pinnacle Lifetime Member for his contributions to the Medical field.

Key Points: 
  • CHELTENHAM, Pa., March 6, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Bohdan Minczak is acknowledged as a Pinnacle Lifetime Member for his contributions to the Medical field.
  • Dr. Bohdan Minczak is a distinguished emergency medicine physician with a rich background in healthcare, research, and academia.
  • Dr. Minczak is a renowned specialist in the realm of emergency medicine, with a deep understanding of physiology and biophysics.
  • His multifaceted expertise extends to public speaking and lecturing, enabling him to effectively communicate complex medical concepts to diverse audiences.

CEO Munjal Shah To Demo 'Super-Staffing' Health Care LLM at the Commonwealth Club of California

Retrieved on: 
Thursday, February 1, 2024
Intelligence, SAN, Thomas Jefferson University, AI, Hippocrates, Commonwealth Club, Jefferson Health, MBA, Health, LLM, Commonwealth

The event, to be held on Feb. 12, will address the critical staffing crisis in health care and demonstrate an LLM that provides services such as chronic care and patient navigation.

Key Points: 
  • The event, to be held on Feb. 12, will address the critical staffing crisis in health care and demonstrate an LLM that provides services such as chronic care and patient navigation.
  • The health care industry is grappling with a severe staffing shortage, with demand far outstripping the supply of sector professionals.
  • In introducing the concept of "super-staffing," Shah envisions a future where AI helps provide high-quality care that's infinitely scalable, improving health care equity, access, and outcomes.
  • This display will feature Shah as a patient interacting with a "digital nurse assistant" in a typical health care scenario.

IFAS Acquires 16th Location

Retrieved on: 
Tuesday, January 2, 2024
General Health, Health Technology, Health, Physical Therapy, Private equity, Acquisition, Foot, Jefferson Health, Calendar, Overalls, Patient

This transaction marked the fifth acquisition of the calendar year, the first full calendar year of operations for the company.

Key Points: 
  • This transaction marked the fifth acquisition of the calendar year, the first full calendar year of operations for the company.
  • During 2023, IFAS also completed the acquisitions of Foot & Ankle Center of Chester County, Berkshire Podiatry, Bryn Mawr Foot & Ankle Center and Lancaster Podiatry.
  • IFAS commenced operations in 2022 as a joint venture between Avonwood Capital Partners and Mereo Capital Partners, two suburban Philadelphia-based Private Equity firms with a background in healthcare investing and operations.
  • IFAS is in active discussions to expand our network of practices in the Mid-Atlantic and Northeast with potential doctor-partners in Pennsylvania, New Jersey, New York, Delaware, Maryland and Virginia.